| Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases M Mehta, D Tewari, G Gupta, R Awasthi, H Singh, P Pandey, ... Chemico-biological interactions 308, 206-215, 2019 | 760 | 2019 |
| Emerging trends in the novel drug delivery approaches for the treatment of lung cancer P Sharma, M Mehta, DS Dhanjal, S Kaur, G Gupta, H Singh, ... Chemico-biological interactions 309, 108720, 2019 | 642 | 2019 |
| Antibacterial and antioxidant potential of biosynthesized copper nanoparticles mediated through Cissus arnotiana plant extract S Rajeshkumar, S Menon, SV Kumar, MM Tambuwala, HA Bakshi, ... Journal of Photochemistry and Photobiology B: Biology 197, 111531, 2019 | 629 | 2019 |
| The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress K Dua, R Wadhwa, G Singhvi, V Rapalli, SD Shukla, MD Shastri, G Gupta, ... Drug development research 80 (6), 714-730, 2019 | 517 | 2019 |
| Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update M Mehta, DS Dhanjal, KR Paudel, B Singh, G Gupta, S Rajeshkumar, ... Inflammopharmacology 28, 795-817, 2020 | 314 | 2020 |
| Dynamics of prolyl hydroxylases levels during disease progression in experimental colitis HA Bakshi, V Mishra, S Satija, M Mehta, FL Hakkim, P Kesharwani, K Dua, ... Inflammation 42, 2032-2036, 2019 | 208 | 2019 |
| Anti‐inflammatory and anticancer activities of Naringenin‐loaded liquid crystalline nanoparticles in vitro R Wadhwa, KR Paudel, LH Chin, CM Hon, T Madheswaran, G Gupta, ... Journal of food biochemistry 45 (1), e13572, 2021 | 192 | 2021 |
| Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: an emerging need for novel drug delivery systems K Dua, V Malyla, G Singhvi, R Wadhwa, RV Krishna, SD Shukla, ... Chemico-biological interactions 299, 168-178, 2019 | 123 | 2019 |
| Knowledge management research in the construction industry: a review D Yu, J Yang Journal of the Knowledge Economy 9, 782-803, 2018 | 100* | 2018 |
| Patented therapeutic drug delivery strategies for targeting pulmonary diseases AK Thakur, DK Chellappan, K Dua, M Mehta, S Satija, I Singh Expert opinion on therapeutic patents 30 (5), 375-387, 2020 | 99 | 2020 |
| Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases M Mehta, N Sharma, M Vyas, N Khurana, PK Maurya, H Singh, ... Chemico-biological interactions 304, 10-19, 2019 | 98 | 2019 |
| Albumin nano-encapsulation of piceatannol enhances its anticancer potential in colon cancer via down regulation of nuclear p65 and HIF-1α A AA Aljabali, H A. Bakshi, F L. Hakkim, YA Haggag, K M. Al-Batanyeh, ... Cancers 12 (1), 113, 2020 | 97 | 2020 |
| Multi-drug resistant Mycobacterium tuberculosis & oxidative stress complexity: Emerging need for novel drug delivery approaches K Dua, VK Rapalli, SD Shukla, G Singhvi, MD Shastri, DK Chellappan, ... Biomedicine & Pharmacotherapy 107, 1218-1229, 2018 | 87 | 2018 |
| Current-status and applications of polysaccharides in drug delivery systems P Prasher, M Sharma, M Mehta, S Satija, AA Aljabali, MM Tambuwala, ... Colloid and Interface Science Communications 42, 100418, 2021 | 79 | 2021 |
| An overview of vaccine development for COVID-19 SH Shahcheraghi, J Ayatollahi, AAA Aljabali, MD Shastri, SD Shukla, ... Therapeutic delivery 12 (3), 235-244, 2021 | 75 | 2021 |
| Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro KR Paudel, R Wadhwa, XN Tew, NJX Lau, T Madheswaran, ... Life sciences 276, 119436, 2021 | 70 | 2021 |
| Recent developments in alpha-glucosidase inhibitors for management of type-2 diabetes: An update B Usman, N Sharma, S Satija, M Mehta, M Vyas, GL Khatik, N Khurana, ... Current pharmaceutical design 25 (23), 2510-2525, 2019 | 70 | 2019 |
| Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases DK Chellappan, LW Yee, KY Xuan, K Kunalan, LC Rou, LS Jean, LY Ying, ... Drug development research 81 (4), 419-436, 2020 | 69 | 2020 |
| MicroRNAs as biomarker for breast cancer T Aggarwal, R Wadhwa, R Gupta, KR Paudel, T Collet, DK Chellappan, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2020 | 61 | 2020 |
| Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics YY Tan, PK Yap, GLX Lim, M Mehta, Y Chan, SW Ng, DN Kapoor, P Negi, ... Chemico-biological interactions 329, 109221, 2020 | 60 | 2020 |
Saurabh SatijaUniversity of Wollongong, New South Wales, Australia在 uow.edu.au 的电子邮件经过验证
Saurabh SatijaUniversity of Wollongong, New South Wales, Australia在 uow.edu.au 的电子邮件经过验证